Abstract
The insulin-like growth factors (IGF-I and IGF-II) circulate bound to specific proteins. Two classes of binding proteins have been relatively well characterized differing in size, immunological activity, and physiological function. This review summarizes the more recent data on IGF-binding proteins, focusing on their possible clinical implications.
Similar content being viewed by others
Abbreviations
- GH:
-
growth hormone
- IGF-BP:
-
insulin-like growth factor binding protein
- IGF (I and II):
-
insulin-like growth factor (I and II)
References
Adam SO, Kapadia M, Millis B, Daughaday WH (1984) Release of insulin-like growth factors and binding protein activity into serum-free medium of cultured human fibroblasts. Endocrinology 115:520–526
Atkinson PR, Weidman ER, Bhaumik B, Bala RM (1980) Release of somatomedin-like activity by cultured W1-38 human fibroblasts. Endocrinology 106:2006–2012
Bar RS, Harrison LC, Baxter RC, Boes M, Dake BL, Booth B, Cox A (1987) Production of IGF-binding proteins by vascular endothelial cells. Biochem Biophys Res Commun 148:734–739
Bar RS, Boes M, Sandra A (1988) IGF receptors in myocardial capillary endothelium: potential regulation of IGF-I transport to cardiac muscle. Biochem Biophys Res Commun 152:93–98
Baumann G, Stolar MW, Amburn K, Barsano CP, De Vries BC (1986) A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab 62:134–141
Baxter RC (1988) Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 67:265–272
Baxter RC, Cowell CT (1987) Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab 65:432–440
Baxter RC, Martin JL (1986) Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 78:1504–1512
Baxter RC, Martin JL, Wood MH (1987) Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid: relationship to fetal maturity. J Clin Endocrinol Metab 65:423–431
Binoux M, Hossenlopp P (1988) Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab 67:509–514
Binoux M, Hossenlopp P, Lassarre C, Hardouin N (1981) Production of insulin-like growth factors and their carriers by rat pituitary gland and brain explants in culture. FEBS Lett 124:178–184
Binoux M, Hossenlopp P, Hardouin S, Seurin D, Lassarre C, Gourmelen M (1986) Somatomedin (insulin-like growth factors)-binding proteins. Horm Res 24:141–151
Blum WF, Ranke MB, Kietzmann K, Bierich JR (1988) Somatomedin binding protein (SmBP) in normals and in growth hormone deficiency (GHD). Pediatr Res 24:522–31A
Brinkman A, Groffen C, Kortleve DJ, Geurts van Kessel A, Drop SLS (1988) Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (IBP-1). EMBO J 7:2417–2423
Brismar K, Gutniak M, Povoa G, Werner S, Hall K (1988) Insulin regulates the 35 Kda IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 11:599–602
Busby WH, Klapper DG, Clemmons DR (1988) Purification of a 31.000-Dalton insulin-like growth factor binding protein from human amniotic fluid. J Biol Chem 263:14203–14210
Clemmons DR, Underwood LE (1986) Somatomedin-C/insulinlike growth factor I in acromegaly. Clin Endocrinol Metab 15: 629–653
Clemmons DR, Van Wyk JJ (1984) Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab 13:113–143
Clemmons DR, Underwood LE, Chatelain PG, Van Wyk JJ (1983) Liberation of immunoreactive somatomedin-C from its binding proteins by proteolitic enzymes and heparin. J Clin Endocrinol Metab 56:384–389
Cotterill AM, Cowell CT, Baxter RC, McNeil D, Silink M (1988) Regulation of the growth hormone-independent insulin-like growth factor binding protein in children. J Clin Endocrinol Metab 67:882–887
Daughaday WH, Phillips LS, Mueller MC (1976) The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 98:1214–1218
De Larco J, Todaro GJ (1978) A human fibrosarcoma cell line producing multiplication stimulatory activity (MSA)-related peptides. Nature 272:356–358
De Vroede MA, Tseng LYH, Katsoyannis PG, Nissley SP, Rechler MM (1986) Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media. J Clin Invest 77: 602–613
Drop SLS, Valiquette G, Guyda HJ, Corvol MT, Posner BI (1979) Partial purification and characterization of a binding protein for insulin-like activity (ILAs) in human amniotic fluid: a possible inhibitor of insulin-like activity. Acta Endocrinol 90:505–518
Elgin RG, Busby WH, Clemmons DR (1987) An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84:3254–3258
Froesh ER, Burgi H, Muller WA, Humbel RE, Jakob A, Labhart A (1967) Non-suppressible insulin-like activity of human serum: purification, physiochemical and biochemical properties and its relation to total serum ILA. Rec Prog Horm Res 23:565–605
Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ (1977) Estimation of somatomedin-C levels in normal and patients with pituitary disease by radioimmunoassay. J Clin Invest 60:648–657
Hall K, Lundin G, Povoa G (1988) Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly, and anorexia nervosa. Acta Endocrinol 118:321–326
Hardouin S, Hossenlopp P, Seurin D, Portolan G, Lassarre C, Binoux M (1987) Heterogeneity of insulin-like growth factor binding proteins and relationship between structure and affinity. Eur J Biochem 170:121–132
Hintz RL, Liu F, Rosenfeld RG, Kemp SF (1981) Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J Clin Endocrinol Metab 53:100–104
Holly JMP, Biddlecombe RA, Dunger DB, Edge JA, Auriel SA, Howell R, Chard T, Rees LH, Wass JAH (1988) Circadian variation of GH independent IGF-binding protein in diabetes mellitus and its relationship with insulin. A new role for insulin? Clin Endocrinol 29:667–675
Holly JMP, Smith CP, Dunger DB, Edge JA, Biddlecombe RA, Williams AJK, Howell R, Chard T, Savage MO, Rees LH, Wass JAH (1989) The levels of the small IGF-binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty. J Endocrinol 121:383–387
Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M (1986) Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138–143
Julkunen M, Koistinen R, Aalto-Setala K, Seppala M, Janne DA, Kontula K (1988) Primary structure of human insulin-like growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA. FEBS Lett 236:295–302
Koistinen R, Kalkkinen N, Huhtala ML, Seppala M, Bohn H, Rutanen EM (1986) Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid. Endocrinology 118:1375–1378
Leung DW, Spencer SA, Cachianes G, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI (1987) Growth hormone receptor and serum binding protein: purification cloning, and expression. Nature 330:537–543
Martin JL, Baxter RC (1985) Antibody against acid-stable insulin-like growth factor binding protein detects 150,000 mol. wt. growth hormone-dependent complex in human plasma. J Clin Endocrinol Metab 61:799–801
Martin JL, Baxter RC (1988) Insulin-like growth factor-binding proteins (IGF-BPs) produced by human skin fibroblasts: immunological relationship to other human IGF-BPs. Endocrinology 123:1907–1915
Moses AC, Freinkel AJ, Knowles BB, Aden DP (1983) Demonstration that a human hepatoma cell line produces a specific insulin-like growth factor carrier protein. J Clin Endocrinol Metab 56: 1003–1008
Ooi GT, Herington AC (1988) The biological and structural characterization of specific serum binding proteins for the insulin-like growth factors. J Endocrinol 118:7–18
Orlowski CC, Chernausek SD (1988) Discordance of serum and tissue somatomedin levels in growth hormone-stimulated growth in rat. Endocrinology 123:44–49
Povoa G, Roovete A, Hall K (1984) Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol 107:563–570
Rinderknecht E, Humbel RE (1978) The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253:2769–2773
Rinderknecht E, Humbel RE (1978) Primary structure of human insulin-like growth factor II. FEBS Lett 89:283–286
Rutanen EM, Pekonen F, Makinen T (1988) Soluble 34 K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action. J Clin Endocrinol Metab 66:173–180
Salmon WD, Daughaday WH (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825–836
Schalch DS, Heinrich UE, Draznin B, Johnson CJ, Miller LL (1979) Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology 104:1143–1151
Schwander JC, Hauri C, Zapf J, Froesh ER (1983) Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 113:297–305
Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266–272
Suikkari AM, Koivisto VA, Koistinen R, Seppala M, Yki-Jarvinen H (1989) Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab 68:135–140
Tanner JM (1962) Growth and adolescence, 2nd edn. Blackwell, Oxford
Underwood LE, D'Ercole AJ, Clemmons DR, Van Wyk JJ (1986) Paracrine functions of Somatomedins. Clin Endocrinol Metab 15:59–77
Wilkins JR, D'Ercole AJ (1985) Affinity-labeled plasma somatomedin-C/insulin-like growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure. J Clin Invest 75:1350–1358
Zapf J, Schoenle E, Jagars J, Sand I, Grunwald J, Froesch ER (1979) Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. J Clin Invest 63:1077–1084
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cianfarani, S., Holly, J.M.P. Somatomedin-binding proteins: What role do they play in the growth process?. Eur J Pediatr 149, 76–79 (1989). https://doi.org/10.1007/BF01995850
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01995850